arginine has been researched along with Nasopharyngeal Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Huang, C; Li, J; Lu, H; Luo, M; Mao, Y; Wang, X; Wei, L; Zhan, Y | 1 |
| Cao, Y; Chen, Y; He, J; Huang, S; Li, Z; Liu, L; Sun, L; Xu, Z; Yang, L; Zhang, L | 1 |
2 other study(ies) available for arginine and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells.
Topics: 2-Naphthylamine; Apoptosis; Arginine; Cell Line, Tumor; DNA Damage; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Radiation Tolerance | 2021 |
Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model.
Topics: Absorption; Animals; Arginine; Carcinoma; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA, Catalytic; Durapatite; Heterografts; Humans; Intracellular Space; Mice; Nanoparticles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Transfection; Viral Matrix Proteins | 2013 |